No Data
No Data
Regeneron Pharmaceuticals Announces That The European Commission Has Granted Conditional Marketing Approval Of Lynozyfic To Treat Adults With Relapsed And Refractory Multiple Myeloma
Top Gap Ups and Downs on Tuesday: HON, SPOT, BBVA and More
Equity Markets Higher Despite Weak US Consumer Confidence Data
Regeneron Pharma Margins Tighten As Competition Grows, Stock Slides
Why Regeneron (REGN) Stock Is Falling Today
Top Midday Decliners